Suppr超能文献

肥大细胞在大鼠腺苷A3受体介导的低血压中的作用。

A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat.

作者信息

Hannon J P, Pfannkuche H J, Fozard J R

机构信息

Preclinical Research, Sandoz Pharma Ltd., Basel, Switzerland.

出版信息

Br J Pharmacol. 1995 Jul;115(6):945-52. doi: 10.1111/j.1476-5381.1995.tb15902.x.

Abstract
  1. The adenosine A3 receptor agonist, N6-2-(4-aminophenyl)ethyladenosine (APNEA) induces hypotension in the anaesthetized rat. The present experiments were carried out to explore the role of mast cells in the response. 2. Intravenous injection of APNEA (1-30 micrograms kg-1 to rats in which the A3 receptor-mediated response had been isolated by pretreatment with 8-(p-sulphophenyl) theophylline (8-SPT)), induced dose-related falls in blood pressure accompanied at higher doses by small falls in heart rate. Responses to the mast cell degranulating agent, compound 48/80 (10-300 micrograms kg-1, i.v.) were qualitatively similar to those to APNEA. 3. Pretreatment with sodium cromoglycate (0.25-20 mg kg-1, i.v.) induced dose-related, although incomplete, blockade of the hypotensive responses to APNEA. At 20 mg kg-1, sodium cromoglycate also inhibited the cardiovascular response to compound 48/80 but had no effects on those to the selective A1 receptor agonist, N6-cyclopentyladenosine (CPA) or the selective A2A receptor agonist, 2-[p-(2-carboxyethyl)phenylamino]-5'-N-ethylcarboxamidoadenosine (CGS 21680). Lodoxamide (0.01-20 mg kg-1) also blocked selectively but incompletely the response to APNEA. 4. The cardiovascular responses to compound 48/80 (10-300 micrograms kg-1, i.v.) were markedly suppressed in animals which had received repeated doses of the compound by the intraperitoneal route. Similarly APNEA was essentially devoid of cardiovascular activity in such preparations. In contrast, responses to CPA were similar in animals treated repeatedly with compound 48/80 to those obtained in control animals. 5. Plasma and serum histamine concentrations were markedly increased associated with the pronounced hypotensive responses induced by intravenous injections of APNEA (30 or 100 microg kg-1) in the presence of 8-SPT, or compound 48/80 (300 microg kg-1).6. Taken together the data implicate the mast cell in a key role in adenosine A3 receptor-mediated hypotension in the anaesthetized rat.
摘要
  1. 腺苷A3受体激动剂N6-2-(4-氨基苯基)乙基腺苷(APNEA)可使麻醉大鼠血压降低。本实验旨在探讨肥大细胞在该反应中的作用。2. 静脉注射APNEA(1 - 30微克/千克,给予预先用8-(对磺基苯基)茶碱(8-SPT)预处理以分离出A3受体介导反应的大鼠),可引起剂量相关的血压下降,高剂量时伴有心率小幅下降。对肥大细胞脱颗粒剂化合物48/80(10 - 300微克/千克,静脉注射)的反应在性质上与对APNEA的反应相似。3. 色甘酸钠(0.25 - 20毫克/千克,静脉注射)预处理可引起剂量相关的,尽管不完全的,对APNEA降压反应的阻断。在20毫克/千克时,色甘酸钠也抑制了对化合物48/80的心血管反应,但对选择性A1受体激动剂N6-环戊基腺苷(CPA)或选择性A2A受体激动剂2-[对-(2-羧乙基)苯基氨基]-5'-N-乙基羧酰胺腺苷(CGS 21680)的反应无影响。洛度沙胺(0.01 - 20毫克/千克)也选择性地但不完全地阻断了对APNEA的反应。4. 对通过腹腔途径反复给予化合物48/80(10 - 300微克/千克,静脉注射)的动物,其对化合物48/80的心血管反应明显受到抑制。同样,在这样的制剂中APNEA基本没有心血管活性。相比之下,反复用化合物48/80处理的动物对CPA的反应与对照动物相似。5. 在8-SPT存在下,静脉注射APNEA(30或100微克/千克)或化合物48/80(300微克/千克)诱导明显的降压反应时,血浆和血清组胺浓度显著升高。6. 综合这些数据表明,肥大细胞在麻醉大鼠腺苷A3受体介导的低血压中起关键作用。

相似文献

引用本文的文献

5
Toxicological safety evaluation of freeze-dried larva powder.冻干幼虫粉的毒理学安全性评价
Toxicol Rep. 2018 Jun 2;5:695-703. doi: 10.1016/j.toxrep.2018.06.001. eCollection 2018.
8
Pyran Template Approach to the Design of Novel A Adenosine Receptor Antagonists.吡喃模板法用于新型A腺苷受体拮抗剂的设计。
Drug Dev Res. 1999 Dec;48(4):171-177. doi: 10.1002/(SICI)1098-2299(199912)48:4<171::AID-DDR4>3.0.CO;2-5. Epub 2000 Feb 11.

本文引用的文献

1
Compound 48/80: a potent histamine liberator.化合物48/80:一种强效组胺释放剂。
Br J Pharmacol Chemother. 1951 Sep;6(3):499-508. doi: 10.1111/j.1476-5381.1951.tb00661.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验